Skip to main content

Table 1 Professional background and demographic details for survey completers

From: Global health trials methodological research agenda: results from a priority setting exercise

 

Round 1

N = 412

Round 2

N = 314

Years of experience working in clinical trials

  

 Mean (SD)

7.67 (7.02)

7.89 (7.14)

 Median (IQR)

5 (3, 10)

6 (3, 10)

 Range

1, 45

1, 50

Participant disciplines

 Clinical disciplines

268 (65%)

196 (62%)

  Public health

59 (14%)

47 (15%)

  Infectious diseases

57 (14%)

40 (13%)

  General medicine

48 (12%)

27 (9%)

  Paediatrics

24 (6%)

14 (4%)

  General surgery

17 (4%)

13 (4%)

  Nursing

9 (2%)

7 (2%)

  Obstetrics

8 (2%)

12 (4%)

  Primary care

8 (2%)

7 (2%)

  Psychiatry

8 (2%)

3 (1%)

  Dentistry

5 (1%)

2 (1%)

  Oncology

5 (1%)

4 (1%)

  Physiotherapy

3 (1%)

3 (1%)

  Cardiology

2 (<1%)

1 (< 1%)

  Gynaecology

2 (< 1%)

1 (< 1%)

  Haematology

2 (< 1%)

2 (1%)

  Neurosurgery

2 (< 1%)

1 (< 1%)

  Anaesthesia

1 (< 1%)

1 (< 1%)

  Dermatology

1 (< 1%)

1 (< 1%)

  Ear, nose and throat diseases

1 (< 1%)

1 (< 1%)

  Neurology

1 (< 1%)

0 (0%)

  Nutrition

1 (< 1%)

2 (1%)

  Orthopaedics and trauma

1 (< 1%)

6 (2%)

  Pneumology

1 (< 1%)

0 (0%)

  Rheumatology

1 (< 1%)

1 (< 1%)

  Urology

1 (< 1%)

0 (0%)

 Research methods disciplines

85 (21%)

61 (19%)

  Trials management

37 (9%)

19 (6%)

  Statistics

19 (5%)

16 (5%)

  Data management

13 (3%)

10 (3%)

  Epidemiology

7 (2%)

8 (3%)

  Ethics

3 (1%)

2 (1%)

  Quality assurance

2 (< 1%)

2 (1%)

  Clinical research

2 (< 1%)

2 (1%)

  Health economics

1 (< 1%)

1 (< 1%)

  Information systems

1 (< 1%)

0 (0%)

  Mathematics

0 (0%)

1 (< 1%)

 Laboratory science disciplines

37 (9%)

44 (14%)

  Biomedical sciences

12 (3%)

27 (9%)

  Pharmacy

12 (3%)

10 (3%)

  Parasitology

4 (1%)

5 (2%)

  Immunology

3 (1%)

0 (0%)

  Biology

2 (< 1%)

0 (0%)

  Microbiology

2 (< 1%)

1 (< 1%)

  Biotechnology

1 (< 1%)

1 (< 1%)

  Chemistry

1 (< 1%)

0 (0%)

 Other disciplines

22 (5%)

13 (4%)

  Health management (administration)

6 (1%)

3 (1%)

  Social sciences

6 (1%)

4 (1%)

  Community engagement

3 (1%)

1 (< 1%)

  Complementary medicine

3 (1%)

2 (1%)

  Pharmacology

2 (< 1%)

1 (< 1%)

  Medical devices

1 (< 1%)

0 (0%)

  Pharmacogenomics

1 (< 1%)

0 (0%)

  Global health

0 (0%)

1 (< 1%)

  Environmental heath

0 (0%)

1 (< 1%)

Origin of trial experience

 In a low- to middle-income country (LMIC) only

250 (61%)

196 (63%)

 In both a LMIC and a high-income country (HIC)

100 (24%)

76 (24%)

 In a HIC only

62 (15%)

42 (13%)

Involvement in clinical trials

 Design

240 (58%)

174 (55%)

 Conduct

361 (88%)

267 (85%)

 Analysis

213 (53%)

171 (54%)

 Reporting

257 (62%)

200 (64%)

Current residence by continent

 Africa

210 (51%)

171 (54%)

 Asia

82 (20%)

55 (18%)

 Europe

64 (16%)

41 (13%)

 South America

32 (8%)

30 (10%)

 North America

23 (6%)

16 (5%)

 Australia

1 (< 1%)

1 (< 1%)

  1. SD standard deviation, IQR interquartile range